Current epidemiological aspects of acute viral hepatitis in Russia

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: According to the World Health Organization, viral hepatitis is one of the leading causes of death in the world. Mortality in hepatitis A varies from 0.1 to 2.1%, in hepatitis E from 0.1 to 4%, reaching 30% in pregnant women in the third trimester. From the outcomes and complications of hepatitis B and C, up to 1.4 million people die in the world every year.

AIMS: Determine the current aspects of the epidemic process of acute viral hepatitis: in the conditions of polyethylene friendliness, the influence of socio-economic changes taking place in the Russian Federation and measures of specific immunoprophylaxis of hepatitis B and A.

MATERIALS AND METHODS: The analysis of the data of the state statistical reporting of acute viral hepatitis in the Russian Federation (Form No. 2 “Information on infectious and parasitic diseases”) was carried out, the analytical tables developed by the Pasteur Research Institute of Epidemiology and Microbiology and the Reference Center for Monitoring Viral Hepatitis of the FBSI Central were analyzed. Research Institute of Epidemiology of Rospotrebnadzor. To establish the occurrence of polyetiology, a serological study was carried out by ELISA of 275 blood samples obtained from patients hospitalized in an infectious diseases hospital with a laboratory-confirmed diagnosis of hepatitis A (HAVAb IgM) for the presence of hepatitis B markers (HBsAg, HBsAb, HBcAb) and hepatitis С (HCVAb).

RESULTS: The incidence of acute viral hepatitis has reached the elimination rate in children and adults. In 2009 the incidence of acute hepatitis C was 2.2 per 100 thousand of the population, in children under 14 years old ― 0.6 per 100 thousand of the population, and in 2020 the rate decreased to 0.66 per 100 thousand of the population in the whole country up to 0.1 in children. A characteristic feature of the modern epidemic process of hepatitis А is the shift in incidence to age groups 20–39 years. The most common variants of polyetiology are hepatitis A + hepatitis B (74%). The incidence of parenteral hepatitis has been decreasing in the Russian Federation over the past decade due to ongoing anti-epidemic and preventive measures.

CONCLUSION: The current trend in the epidemiology of acute viral hepatitis is a steady decrease in the incidence. The number of new cases of registration of both vaccine-controlled and non-managed acute viral hepatitis has been steadily declining in both children and adults. The most common variants of polyetiology are hepatitis A + hepatitis B (74%).Vaccinal prophylaxis of hepatitis A and hepatitis B remains a necessary measure to combat various variants of the course of mixed infections.

About the authors

Maria Yu. Butskaya

Saint-Petersburg Pasteur Institute; Saint-Petersburg State Pediatric Medical University

Email: butskaya.masha@yandex.ru
ORCID iD: 0000-0003-0933-7972
SPIN-code: 3602-8316

Postgraduate Student

Russian Federation, Saint Petersburg; Saint Petersburg

Anastasia D. Bushmanova

Saint-Petersburg Pasteur Institute; Saint-Petersburg State Pediatric Medical University

Author for correspondence.
Email: nastya1089@mail.ru
ORCID iD: 0000-0002-5010-7856
SPIN-code: 2526-8759

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg; Saint Petersburg

Ekaterina N. Priyma

Saint-Petersburg State Pediatric Medical University

Email: priima-e@rambler.ru
ORCID iD: 0000-0002-2997-0890
SPIN-code: 7348-1450

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Svetlana V. Ogurtsova

Saint-Petersburg Pasteur Institute

Email: svet.ogurtsova@yandex.ru
ORCID iD: 0000-0002-7604-9703
SPIN-code: 5046-3220

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Ksenia E. Novak

Saint-Petersburg State Pediatric Medical University

Email: kseniya.novak@mail.ru
ORCID iD: 0000-0001-9633-4328
SPIN-code: 4026-3720

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Elena V. Esaulenko

Saint-Petersburg Pasteur Institute; Saint-Petersburg State Pediatric Medical University

Email: eve-gpmu@mail.ru
ORCID iD: 0000-0003-3669-1993
SPIN-code: 6210-0424

MD, Dr. Sci. (Med.), Professor

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. WHO global health sector strategy on viral hepatitis. Geneva: World Health Organization; 2016. Available from: https://whodc.mednet.ru/ru/osnovnye-publikaczii/infekczionnye-bolezni-i-borba-s-nimi/virusnyj-gepatit/2537.html Accessed: 15.02.2021.
  2. Esaulenko EV, Alekseeva MV, Sukhoruk AA, et al. Fulminant hepatitis in real clinical practice. Infectious Dis. 2017;15(2):70–74. (In Russ). doi: 10.20953/1729-9225-2017-2-70-74
  3. Novak KE, Karev VE, Dunaeva NV, Esaulenko EV. Postmortal morphological characteristics of the liver of patients with chronic viral hepatitis with clinical signs of cirrhosis. Russ Med J. 2011;17(2):8–11. (In Russ).
  4. Viral hepatitis in the Russian Federation. Analytical review. Issue 11. Ed. by V.I. Pokrovsky, A.A. Totolyan. Saint Petersburg; 2018. 112 p. (In Russ).
  5. Sologub TV, Esaulenko EV, Romantsov MG, et al. HBSAG carrier: condition or disease? Infectious Dis. 2008;6(3):5–10. (In Russ).
  6. Razavi H. Global epidemiology of viral hepatitis. Gastroenterol Clin North Am. 2020;49(2):179–189. doi: 10.1016/j.gtc.2020.01.001
  7. Esaulenko EV, Sukhoruk AD, Bushmanova AA, et al. Epidemiological and molecular genetic features of enteral viral hepatitis in Russia at the present stage. Almanac Clin Med. 2018;46(1):50–58. (In Russ). doi: 10.18786/2072-0505-2018-46-1-50-58
  8. Kankaria A, Gupta M, Bashar MD, et al. Epidemiological investigation of an outbreak of acute viral hepatitis A and E in a semi-urban locality in Chandigarh, North Indian Union Territory, 2016–2017. J Family Med Prim Care. 2020;9(4):1856–1867. doi: 10.4103/jfmpc.jfmpc_1244_19
  9. Mikhailov MI, Malinnikova EY, Kyuregyan KK, Polyakov AD. Hepatitis E ― actual problems of studying (2016–2018). Infectious Dis News Opinions training. 2019;8(1):74–83. (In Russ). doi: 10.24411/2305-34962019-11010
  10. Novak KE, Bushmanova AD. Epidemiological situation of viral hepatitis A in St. Petersburg. Med Theory Practice. 2019;4(suppl.): 389–390. (In Russ).
  11. Joon A, Rao P, Shenoy SM, et al. Prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis. J Med Microbiol. 2015;33 Suppl.:102–105. doi: 10.4103/0255-0857.150908
  12. Clemente-Casares P, Ramos-Romero C, Ramirez-Gonzalez E, Mas A. Hepatitis E virus in industrialized countries: the silent threat. Biomed Res. 2016:9838041. doi: 10.1155/2016/9838041
  13. Oorzhak ND. Epidemiological characteristics of parenteral viral hepatitis (hepatitis VIS) in the Republic of Tyva. Infection Immunity. 2017;(S):50. (In Russ).
  14. Polyanina AV, Bystrova TN, Zalesskikh AA, et al. Epidemiological features of hepatitis B in the Nizhny Novgorod region in the conditions of vaccination. In: Collection of materials of the XI Annual All-Russian Congress on Infectious Diseases with international participation, April 1–3, 2019. Moscow; 2019. 163 p. (In Russ).
  15. Esaulenko EV, Alekseeva MV, Sukhoruk AA, et al. Fulminant hepatitis in real clinical practice. Infectious Dis. 2017;15(2):70–74. (In Russ). doi: 10.20953/1729-9225-2017-2-70-74
  16. Esaulenko EV, Sukhoruk AA. Liver transplantation in childhood and in adults. Pediatrician (St. Petersburg). 2015;6(3):98–103. (In Russ). doi: 10.17816/PED6398-103
  17. Inoue T, Tanaka Y. Cross-Protection of hepatitis B vaccination among different genotypes. Vaccines (Basel). 2020;8(3):456. doi: 10.3390/vaccines8030456
  18. Castaneda D, Gonzalez AJ, Alomari M, et al. From hepatitis A to E: a critical review of viral hepatitis. World J Gastroenterol. 2021;27(16):1691–1715. doi: 10.3748/wjg.v27.i16.1691
  19. Sperle I, Steffen G, Leendertz SA, et al. Prevalence of hepatitis B, C, and D in Germany: results from a scoping review. Front Public Health. 2020;8:424. doi: 10.3389/fpubh.2020.00424
  20. Hassan-Kadle MA, Osman MS, Ogurtsov PP. Epidemiology of viral hepatitis in Somalia: systematic review and meta-analysis study. World J Gastroenterol. 2018;24(34):3927–3957. doi: 10.3748/wjg.v24.i34.3927
  21. Malinnikova EY, Kyuregyan KK, Polyakov AD, et al. Viral hepatitis E. A modern view of the problem. Medicine Extreme Situations. 2018;20(3):293–299. (In Russ).
  22. Stuurman AL, Marano C, Bunge EM, et al. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines ― a systematic review. Hum Vaccin Immunother. 2017;13(3):724–736. doi: 10.1080/21645515.2016.1242539
  23. Bushmanova AD, Novak KE, Ivanova NV. Enteral hepatitis in countries with different endemicity. Topical issues of socially significant infectious and parasitic diseases: proceedings of the 20th Russian-Italian Conference, September 17–18, 2020. Velikii Novgorod; 2020. Р. 7–11. (In Russ).
  24. Jefferies M, Rauff B, Rashid H, et al. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018;6(13):589–599. doi: 10.12998/wjcc.v6.i13.589
  25. Shakhgildyan IV, Mikhailov MI, Ershova ON, et al. Modern epidemiological features of hepatitis A and the effectiveness of universal mass vaccination among children. Current Pediatrics. 2010;9(3):131–135. (In Russ).
  26. Stuurman AL, Marano C, Bunge EM, et al. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines ― a systematic review. Hum Vaccin Immunother. 2017;13(3):724–736. doi: 10.1080/21645515.2016.1242539
  27. Sun XJ, Zhang GM, Zhou RJ, et al. Changes in the epidemiology hepatitis A in three socio-economic regions of China, 1990–2017. Infect Dis Poverty. 2019;8(1):80. doi: 10.1186/s40249-019-0591-z

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. Morbidity of acute viral hepatitis in the territory of the Russian Federation in 2009–2020.Note: ОГЕ ― acute hepatitis E; ОГВ ― acute hepatitis B; ОГА ― acute hepatitis A; ОГС ― acute hepatitis C.

Download (363KB)

Copyright (c) 2021 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies